|
The Leslie and Susan Gonda (Goldschmied) Diabetes and Genetic Research Center is positioned to secure both national and international recognition for excellence in the management of patients with the following:
- Advancing the management of neuroendocrine tumors with the use of radioactive iodine MIBG.
- Providing high-quality comprehensive endocrine care for patients undergoing treatment for non-endocrine cancers.
- Continued clinical research in thyroid cancer exploring new diagnostic and therapeutic alternatives to radioactive iodine therapy.
- Providing compassionate use of recombinant human thyroid stimulating hormone (Thyrogen) for thyroid cancer therapy.
- Investigation of endocrine complications as a result of chemotherapy, radiation therapy and bone marrow transplant in cancer patients.
- Management of immunosuppressive therapy related endocrine complications.
- Aggressive prevention and treatment of bone marrow transplant osteoporosis in both men and women.
- Management of male and female sexual dysfunction in premature gonadal/ovarian failure patients.
- Clinical research in male sexual dysfunction in patients with cancer and diabetes.
- Development of clinical practice guidelines for the management of hypothalamic-pituitary endocrine complications after bone marrow transplant.
- Comprehensive weight management program involving a team of physicians, psychologist, dietitian, nurses and rehabilitation specialist.
- Research in management of diabetic nephropathy and other diabetes related complications.
|